Investment Banking
Joint Bookrunner on Coherus Oncology’s $50.1MM CMPO
February 25, 2026
Oppenheimer & Co. Inc. acted as Joint Bookrunner on Coherus Oncology’s $50.1MM Confidentially Marketed Public Offering
Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), announced the closing of its underwritten public offering of 28,600,000 shares of the Company’s common stock (the “Offering”). The shares of common stock were sold at a public offering price of $1.75 per share. All shares in the Offering were sold by the Company. The gross proceeds to Coherus from the Offering were approximately $50.1 million, before deducting underwriting discounts and commissions. The Offering was led by new investors Janus Henderson Investors, HBM Healthcare Investments and Samsara BioCapital.
Coherus intends to use the net proceeds from the Offering to support the ongoing commercialization of LOQTORZI® (toripalimab-tpzi), to continue clinical development of its product candidates, and for working capital and other general corporate purposes.
Healthcare Life Sciences Investment Banking
Name:
Michael A. Margolis, R.Ph.
Title:Senior Managing Director, Head of Healthcare Life Sciences Investment Banking
DISCLOSURES
This notice is provided for informational purposes only and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.
Oppenheimer & Co. Inc. Transacts Business on all Principal US Exchanges and is a Member of SIPC 8782983.1